greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2021

Sanofi (SNY) annual results, year to 31 December 2021: revenue EUR 37,761 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2021 it reported revenue from the sale of goods of EUR 37,761 million ($44.7 billion at the year's average rate), up 4.8% on the year before. Its profit attributable to shareholders was EUR 6,223 million, down 49.4%.

Revenue
EUR 37,761 million
+4.8% on the year
FY2015FY2021
Operating margin
21.5%
39.2% a year earlier
FY2015FY2021
Net income
EUR 6,223 million
-49.4% on the year
FY2015FY2021
Diluted EPS
n/a
FY2015FY2021

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2020 †Dec 2021
Revenue from the sale of goods36,04137,761
Cost of sales12,15912,255
Gross profit25,21026,920
Research and development5,5305,692
Selling, general and administrative9,3919,555
Operating profit14,1138,126
Finance costs388368
Income tax1,8071,558
Profit for the year12,3306,279
Profit attributable to shareholders12,2946,223
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2020 †Dec 2021
Diluted EPS9.77n/a
Basic EPS9.82n/a
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2020 †Dec 2021
Cash from operations7,41810,522
Cash from investing3,619-7,298
Cash from financing-6,485-7,056
Buybacks822382
Dividends paid3,9374,008
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2020 †Dec 2021
Funded by
Equity attributable to shareholders63,10668,681
Non-controlling interests146350
Borrowings, as filed22,63120,250
Lease liabilities2,1082,108
Other liabilities26,42228,853
Total equity and liabilities114,413120,242
Owned
Property, plant and equipment9,36510,028
Goodwill44,36448,056
Other intangible assets18,34121,407
Cash and cash equivalents13,91510,098
Inventories8,3528,715
Other assets20,07621,938
Total assets114,413120,242
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2020 †Dec 2021
Return on year-end equity19.5%9.1%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2021, filed 23 February 2024: the filing. The figures are in euros as filed.